COSM - Cosmos climbs 11% on Cana Laboratories acquisition expanding product line and integrating vertically
- An international pharmaceutical company, Cosmos ( NASDAQ: COSM ) to acquire Pharmaceutical Laboratories Cana.
- Pharmaceutical Laboratories Cana is a Greek pharmaceutical company that manufactures, sells, distributes, and markets original branded products researched and developed by leading global pharmaceutical and healthcare companies.
- It has manufactured and distributed a broad range of proprietary pharmaceutical and health related products and has operated as a trusted partner of multinational pharmaceutical companies such as AstraZeneca, Janssen, Merck and Viatris, Nestle, Unilever and P&G.
- Greg Siokas, CEO, commented, "We welcome Cana to our group, an acquisition that delivers on our commitment to grow via strategic M&As. We believe this acquisition not only will allow us to realize numerous synergies but will also be a transformative for Cosmos by strengthening our vertical integration and expanding our product portfolio."
- Stock jumps 11% pre-market.
For further details see:
Cosmos climbs 11% on Cana Laboratories acquisition, expanding product line and integrating vertically